Cargando…
Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. As a clinical empirical prescription of traditional Chinese medicine, Qushi Huayu decoction (QHD) has attracted considerable attention for its advantages in multi-target treatment of NAFLD. However, the intervention...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600383/ https://www.ncbi.nlm.nih.gov/pubmed/37900123 http://dx.doi.org/10.3389/fendo.2023.1272214 |
_version_ | 1785125979566374912 |
---|---|
author | Ni, Yiming Wang, Xin Wu, Qian Yao, Yichen Xu, Yuan Li, Yuanyuan Feng, Qin Zhou, Mingmei Gou, Xiaojun |
author_facet | Ni, Yiming Wang, Xin Wu, Qian Yao, Yichen Xu, Yuan Li, Yuanyuan Feng, Qin Zhou, Mingmei Gou, Xiaojun |
author_sort | Ni, Yiming |
collection | PubMed |
description | INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. As a clinical empirical prescription of traditional Chinese medicine, Qushi Huayu decoction (QHD) has attracted considerable attention for its advantages in multi-target treatment of NAFLD. However, the intervention mechanism of QHD on abnormal lipid levels and gut microbiota in NAFLD has not been reported. METHODS: Therefore, we verified the therapeutic effect of QHD on high-fat diet (HFD)-induced NAFLD in rats by physiological parameters and histopathological examination. In addition, studies on gut microbiota and serum lipidomics based on 16S rRNA sequencing and ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS) were conducted to elucidate the therapeutic mechanism of NAFLD in QHD. RESULTS: The changes in gut microbiota in NAFLD rats are mainly reflected in their diversity and composition, while QHD treated rats restored these changes. The genera Blautia, Lactobacillus, Allobaculum, Lachnoclostridium and Bacteroides were predominant in the NAFLD group, whereas, Turicibacter, Blautia, Sporosarcina, Romboutsia, Clostridium_sensu_stricto_1, Allobaculum, and Psychrobacter were predominant in the NAFLD+QHD group. Lipid subclasses, including diacylglycerol (DG), triglycerides (TG), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidic acid (PA), phosphatidylserine (PS), lysophosphatidylinositol (LPI), and phosphatidylglycerol (PG), were significantly different between the NAFLD and the control groups, while QHD treatment significantly altered the levels of DG, TG, PA, lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), and platelet activating factor (PAF). Finally, Spearman’s correlation analysis showed that NAFLD related differential lipid molecules were mainly associated with the genera of Bacteroides, Blautia, Lachnoclostridium, Clostridium_sensu_stricto_1, and Turicibacter, which were also significantly correlated with the biological parameters of NAFLD. DISCUSSION: Taken together, QHD may exert beneficial effects by regulating the gut microbiota and thus intervening in serum lipids. |
format | Online Article Text |
id | pubmed-10600383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106003832023-10-27 Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids Ni, Yiming Wang, Xin Wu, Qian Yao, Yichen Xu, Yuan Li, Yuanyuan Feng, Qin Zhou, Mingmei Gou, Xiaojun Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. As a clinical empirical prescription of traditional Chinese medicine, Qushi Huayu decoction (QHD) has attracted considerable attention for its advantages in multi-target treatment of NAFLD. However, the intervention mechanism of QHD on abnormal lipid levels and gut microbiota in NAFLD has not been reported. METHODS: Therefore, we verified the therapeutic effect of QHD on high-fat diet (HFD)-induced NAFLD in rats by physiological parameters and histopathological examination. In addition, studies on gut microbiota and serum lipidomics based on 16S rRNA sequencing and ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS) were conducted to elucidate the therapeutic mechanism of NAFLD in QHD. RESULTS: The changes in gut microbiota in NAFLD rats are mainly reflected in their diversity and composition, while QHD treated rats restored these changes. The genera Blautia, Lactobacillus, Allobaculum, Lachnoclostridium and Bacteroides were predominant in the NAFLD group, whereas, Turicibacter, Blautia, Sporosarcina, Romboutsia, Clostridium_sensu_stricto_1, Allobaculum, and Psychrobacter were predominant in the NAFLD+QHD group. Lipid subclasses, including diacylglycerol (DG), triglycerides (TG), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidic acid (PA), phosphatidylserine (PS), lysophosphatidylinositol (LPI), and phosphatidylglycerol (PG), were significantly different between the NAFLD and the control groups, while QHD treatment significantly altered the levels of DG, TG, PA, lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), and platelet activating factor (PAF). Finally, Spearman’s correlation analysis showed that NAFLD related differential lipid molecules were mainly associated with the genera of Bacteroides, Blautia, Lachnoclostridium, Clostridium_sensu_stricto_1, and Turicibacter, which were also significantly correlated with the biological parameters of NAFLD. DISCUSSION: Taken together, QHD may exert beneficial effects by regulating the gut microbiota and thus intervening in serum lipids. Frontiers Media S.A. 2023-10-11 /pmc/articles/PMC10600383/ /pubmed/37900123 http://dx.doi.org/10.3389/fendo.2023.1272214 Text en Copyright © 2023 Ni, Wang, Wu, Yao, Xu, Li, Feng, Zhou and Gou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Ni, Yiming Wang, Xin Wu, Qian Yao, Yichen Xu, Yuan Li, Yuanyuan Feng, Qin Zhou, Mingmei Gou, Xiaojun Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids |
title | Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids |
title_full | Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids |
title_fullStr | Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids |
title_full_unstemmed | Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids |
title_short | Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids |
title_sort | qushi huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600383/ https://www.ncbi.nlm.nih.gov/pubmed/37900123 http://dx.doi.org/10.3389/fendo.2023.1272214 |
work_keys_str_mv | AT niyiming qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids AT wangxin qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids AT wuqian qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids AT yaoyichen qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids AT xuyuan qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids AT liyuanyuan qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids AT fengqin qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids AT zhoumingmei qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids AT gouxiaojun qushihuayudecoctionamelioratesnonalcoholicfattyliverdiseaseinratsbymodulatinggutmicrobiotaandserumlipids |